Trial intelligence / Profile preview

MIRTOS: Ticagrelor vs Clopidogrel in STEMI Treated With Thrombolysis

NCT02429271Phase 3Completed

Sponsor
Hellenic Cardiovascular Research Society
Start
Aug 2015
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ticagrelor in ST-elevation myocardial infarction (STEMI), sponsored by Hellenic Cardiovascular Research Society. Started Aug 2015; status: completed.

02

Drugs

ticagrelor
03

Conditions

ST-elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02429271.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02429271.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call